Antinociceptive effects of (+)-matrine in mice

European Journal of Pharmacology

Volumn 337, Issue 2-3, 1997, Pages 223-226

  Kamei, Junzo ^a   Xiao, Ping ^a   Ohsawa, Masahiro ^a   Kubo, Hajime ^a   Higashiyama, Kimio ^a   Takahashi, Hiroshi ^a   Li, Jiashi ^b   Nagase, Hiroshi ^c   Ohmiya, Shigeru ^a  

^a HOSHI UNIVERSITY   (Japan)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

Opioid receptor; Antinociception; Matrine; Mouse; Nor binaltorphimine; Pentazocine

Indexed keywords

ANTINOCICEPTIVE AGENT; KAPPA OPIATE RECEPTOR; MATRINE; MU OPIATE RECEPTOR; NALTRINDOLE; OPIATE RECEPTOR; PENTAZOCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOISOMERISM;

ABDOMEN; ALKALOIDS; ANALGESICS; ANIMALS; MALE; MICE; MICE, INBRED ICR; MUSCLE CONTRACTION; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; QUINOLIZINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TAIL;

EID: 0030693612     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01273-9     Document Type: Article

References (11)

1. Cho C., Chuang C., Chen C. Study of the antipyretic activity of matrine. A lupine alkaloid isolated from Sophora subprostrata. Planta Med. 52:1986;343-345.
2. Kamei J., Suzuki T., Misawa M., Nagase H., Kasuya Y. Antinociceptive effect of dihydroetorphine in diabetic mice. Eur. J. Pharmacol. 275:1995;109-113.
3. Kojima R., Fukushima S., Ueno A., Saiki Y. Antitumor activity of Leguminosae plants constituents. I. Antitumor activity of constituents of Sophora subprostrata. Chem. Pharm. Bull. 18:1970;2555-2563.
4. Okuda S., Yoshimoto M., Tsuda K., Utzugi N. Über die absolute Konfiguration des Matrins. Chem. Pharm. Bull. 14:1966;314-318.
5. Ohmiya, S., Saito, K., Murakoshi, I., 1995. Lupin alkaloids. In: Cordell, G.A. (Ed.), The Alkaloids, vol. 47. Academic Press, New York, NY, pp. 1-114.
6. Reisine, T., Pasternak, G., 1996. Opioid analgesics and antagonists. In: Hardman, J.G., Goodman Gilman, A., Limbird, L.E. (Eds.), The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill, New York, NY, pp. 521-555.
7. Tan H., Zhang B. Antiinflammatory effects of matrine. Chin. J. Integrat. Trad. West. Med. 5:1985;108-110.
8. Ueno A., Morinaga K., Fukushima S., Iitaka Y., Koiso Y., Okuda S. Studies on lupin alkaloids. VI. Isolation and structure of (+)-isomatrine. Chem. Pharm. Bull. 23:1975;2560-2566.
9. Von Voigtlander P.F., Lahti R.A., Ludens J.H. U-50,488: A selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224:1982;7-12.
10. Xiao P., Li J., Kubo H., Saito K., Murakoshi I., Ohmiya S. (-)14b-Hydroxymatrine, A new lupine alkaloid from the roots of S. tonkinensis. Chem. Pharm. Bull. 44:1996;1951-1953.
11. Yamazaki M., Arai A., Suzuki S., Takeuchi T. Protective effects of matrine and oxymatrine on stress ulcer in relation to their effects on the central nervous system. J. Pharm. Soc. Jpn. 104:1984;293-301.